Clinical Trials Directory

Trials / Completed

CompletedNCT02518295

β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion

β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion: Probiotic and Lactose Intolerance

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to assess that two β-galactosidase Producing Probiotic Strains help improve lactose digestion in subjects with lactose maldigestion.

Detailed description

The trial will be cross over, randomized in incomplete blocks, controlled, double-blind: each subject will be administered 3 products out of 4 (positive control, probiotic Streptococcus (S.) thermophilus, probiotic Bifidobacterium (B.) longum, negative control) in a random order on 3 different days separated by a washout period of at least one week, and maximum 2 weeks between each challenge. The total sample size is 42 enrolled subjects/37 completed Patients will be males and females aged between 20 and 65 years with positive hydrogen breath test.

Conditions

Interventions

TypeNameDescription
OTHERPositive control200ml milk containing 18g lactose
OTHERProbiotic S. thermophilus200ml milk containing 18g lactose + probiotic S. thermophilus
OTHERProbiotic B. longum200ml milk containing 18g lactose + probiotic B. longum
OTHERNegative control200 ml of UHT Lactose free milk

Timeline

Start date
2015-09-01
Primary completion
2016-06-01
Completion
2016-09-01
First posted
2015-08-07
Last updated
2016-11-30

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02518295. Inclusion in this directory is not an endorsement.